This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
The investigation focuses on whether the Company and its executives violated federal securities laws with respect to its disclosures concerning business, operational, and compliance policies. Specifically, the investigation focuses on whether Amyris made false and misleading statements to the investing public regarding its ability to produce Biofene, a renewable chemical.
February 9, 2012, the Company disclosed that there would be a decrease in Biofene production and that it needed to raise funds. Following this news, Amyris' stock dropped
$2.74, or over 28%.
Request more information now by clicking here: www.faruqilaw.com/AMRS. There is no cost or obligation to you.Take Action
If you invested in Amyris' stock or options between
April 29, 2011 and
February 8, 2012 and would like to discuss your legal rights, visit
www.faruqilaw.com/AMRS. You can also contact us by calling
Richard Gonnello or
Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to
email@example.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding Amyris' conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (
www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
FARUQI & FARUQI, LLP369 Lexington Avenue, 10th Floor
New York, NY 10017Attn:
Richard Gonnello, Esq.firstname.lastname@example.orgFrancis McConville, Esq.email@example.comTelephone: (877) 247-4292 or (212) 983-9330
SOURCE Faruqi & Faruqi, LLP